Significant Accounting Policies (Details 3) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | |||
Beginning Balance | $ 1,005,490 | $ 882,298 | |
Fair value of warrants and capital note | (25,936) | (19,278) | $ 235,382 |
Fair value of warrants to investors | 183,260 | 142,470 | 457,501 |
Changes in Fair value of warrants and capital note | (74,160) | ||
Ending Balance | 1,005,490 | 882,298 | |
Level 3 [Member] | |||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | |||
Beginning Balance | 1,005,490 | 882,298 | |
Fair value of warrants and capital note | 882,298 | ||
Fair value of warrants to investors | 183,260 | 142,470 | |
Changes in Fair value of warrants and capital note | (25,936) | (19,278) | |
Ending Balance | $ 1,162,814 | $ 1,005,490 | $ 882,298 |
X | ||||||||||
- Definition Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|